Elevated levels of the inflammatory cytokine transforming growth factor-beta (TGF-β) in breast tumors are associated with advanced disease stages and poor prognosis, often leading to bone and lung metastases [45]. This evidence concerns the gene TGFB1 and breast neoplasm.